Global Biological Drugs Market : Segment Snapshot and Table of Content (2014 – 2020)
Global Biological Drugs Market to Reach US$287 bn by 2020, Increasing Prevalence of Chronic Diseases Drives Growth
A research study, recently published by Transparency Market Research (TMR) estimates the global biological drugs market to expand at a healthy CAGR of 10.1% over the period from 2014 to 2020 and reach US$287.14 bn by the end of the forecast period.The research report, titled “Biological Drugs Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 – 2020,” states that the worldwide biological drugs market reached a value of US$161.05 bn in 2014.
Read Report overview @ https://www.transparencymarketresearch.com/biological-drugs-market.html
The Global Biological Drugs Market is segmented on the basis of expression system, By Therapeutic Protein, By Vaccine, application, region.
By vaccine, Varivax, Ceravix, Gardasil, Fluzoone, and Prenvar 13 have been recognized as the major segments of the global market for biological drugs and Prevnar 13 has been identified as the fastest growing segment among them in this study.
On the regional basis, the research report has segmented the global biological drugs market into Asia Pacific, Europe, North America, and the Rest of the World. North America accounted for the largest share in the overall market in 2014. Analysts expect this regional market to witness steady growth over the forecast period due to the expanding application base of biological drugs and their increasing usage in the treatment of various conditions such as diabetes and cancer.
Although the market in North America has experienced a rise in its valuation over the past few years, it is the Asia Pacific market, which is considered as the most attractive regional market for biological drugs among manufacturers. The availability of a skilled workforce required for drug production in Asia Pacific at much lower rates has attracted a number of drugmakers for investing in this region, thereby stimulating the Asia Pacific market for biological drugs, notes the study.
Summary of Table of Content:
2 Executive Summary
3 Global Biological Drugs Market – Industry Analysis
4 Market Trends 5 Porter’s Five Forces Analysis
6 Global Market Size and Forecast
7 Segment Analysis, by Therapeutic Protein
8 Segment Analysis, by mAb
9 Segment Analysis, by Vaccine
10 Regional Analysis1 Pipeline Biologic Drugs
12 Competitive Landscape
13 Company Profiles
Request to Browse Full Table of Content, figure and Tables @ https://www.transparencymarketresearch.com/report-toc/1694